Geode Capital Management
BLTE

Geode Capital Management’s Belite Bio BLTE Stock Holding History

Geode Capital Management’s Portfolio BLTE Stock Details BLTE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.49M Buy
22,640
+12,213
+117% +$1.87M ﹤0.01% 3056
2026
Q1 		$1.66M Sell
10,427
-18
-0.2% -$3.03K ﹤0.01% 3192
2025
Q4 		$1.67M Sell
10,445
-5,180
-33% -$614K ﹤0.01% 3224
2025
Q3 		$1.16M Buy
15,625
+2,761
+21% +$181K ﹤0.01% 3341
2025
Q2 		$742K Buy
12,864
+111
+0.9% +$6.77K ﹤0.01% 3426
2025
Q1 		$845K Buy
12,753
+6,053
+90% +$365K ﹤0.01% 3360
2024
Q4 		$423K Hold
6,700
– – ﹤0.01% 3661
2024
Q3 		$314K Hold
6,700
– – ﹤0.01% 3751
2024
Q2 		$306K Hold
6,700
– – ﹤0.01% 3757
2024
Q1 		$257K Hold
6,700
– – ﹤0.01% 3856
2023
Q4 		$307K Hold
6,700
– – ﹤0.01% 3790
2023
Q3 		$212K Buy
+6,700
New +$168K ﹤0.01% 3959
2022
Q4 		– Sell
-7,264
Closed -$245K – 4901
2022
Q3 		$245K Buy
+7,264
New +$251K ﹤0.01% 4083

Other funds holding BLTE

DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $44.4B AUM 57.89% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management's BLTE Position: Q2 2026 in Review

Geode Capital Management increased its Belite Bio (BLTE) stake by 117% in Q2 2026, buying an estimated $1.87M and bringing the position to 22,640 shares worth $3.49M. The position accounts for ﹤0.01% of the portfolio, ranked #3056.

Geode Capital Management first reported a position in BLTE in Q3 2022 and has held it in 13 quarters since. 80 funds tracked by Wall St. Rank hold BLTE as of Q2 2026.

  • Geode Capital Management held 22,640 shares of Belite Bio worth $3.49M as of Q2 2026.
  • Geode Capital Management bought 12,213 Belite Bio shares in Q2 2026, an estimated $1.87M.
  • Belite Bio made up ﹤0.01% of Geode Capital Management's portfolio in Q2 2026, its #3056 holding.
  • Geode Capital Management first reported a position in Belite Bio in Q3 2022 and has held it in 13 quarters since.
  • 80 funds tracked by Wall St. Rank held Belite Bio as of Q2 2026.

Based on Geode Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.